Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Methionine and Colforsin

supplement:

Methionine

Research Papers that Mention the Interaction

Exposure of the HT29 cells to 10−5 M forskolin in the early stages of growth induction (within 12 h from FCS addition or within 14 h from insulin treatment) resulted in a significant inhibition of DNA synthesis and a delayed entry in the S phase.
Journal of cellular physiology  •  1992  |  View Paper
Forskolin , over a concentration range of 10−7–10−5 M , dose-dependently increased short circuit current (Isc) and transmural potential differences (Vms).
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
Nicorandil 3 × 10 M also potentiated the relaxations induced by forskolin 3 × 10 9-10 6M and dibutylyl-cyclic AMP 3 × 10-6-3 × 10 -4M.
Journal of cardiovascular pharmacology  •  1995  |  View Paper
Pretreatment with 10−6 M PMA for 30 min did not affect PTH receptor binding but significantly augmented a cAMP responsiveness to 10−5 M forskolin and 1 ug/ml cholera toxin.
Journal of cellular physiology  •  1994  |  View Paper
Forskolin (10−9 M) potentiated the vasodilation caused by 10−6 M NECA, thus implicating adenylate cyclase activation during NECA-induced vasodilation and providing further support for involvement of the A2 receptor.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism  •  1991  |  View Paper
M ) inhibited the effect of forskolin (combined with IBMX) in a concentration-dependent and spiroperidol-sensitive manner, and did not modify the action of dibutyrylcyclic AMP.
Neurochemistry International  •  1990  |  View Paper